| article_id i : | 474 |
| pubmed_id i : | 18971477 |
| doi i : | 10.1523/JNEUROSCI.2391-08.2008 |
| pdf_filename i : | Mickey_et_al_2008 |
| title i : | Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo |
| citation i : | (2008) Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. The Journal of neuroscience : the official journal of the Society for Neuroscience. 10.1523/JNEUROSCI.2391-08.2008 |
| include i : | 1 |
| independent i : | 1 |
| comments i : | No comments |
| status i : | 1 |
| creation_time i : | 2022-08-18 12:32:56 |
| modification_time i : | 2024-05-30 11:42:47 |
| created_by i : | joupes |
| modified_by i : | lihsun |
| contrast_id i : | 890 |
| contrast_name i : | 5-HT1A binding potential in each of the 12 identified brain regions in healthy controls versus unmedicated MDD patients |
| article_id i : | 474 |
| modality i : | PET |
| target_molecule i : | 5-HT1A |
| tracer i : | [11C]WAY-100635 |
| model i : | Reference model (cerebellum) |
| include i : | 1 |
| independent i : | 1 |
| comments i : | |
| age_g1 i : | 34 |
| age_g1_males i : | -1 |
| age_g1_females i : | -1 |
| n_g1 i : | 17 |
| n_g1_males i : | 9 |
| n_g1_females i : | 8 |
| disorder_g1 i : | Healthy Controls |
| comorbidity_g1 i : | |
| premedication_g1 i : | |
| medicated_g1 i : | 0 |
| days_wo_drugs_g1 i : | -1 |
| smoking_g1 i : | -1 |
| age_g2 i : | 38 |
| age_g2_males i : | -1 |
| age_g2_females i : | -1 |
| n_g2 i : | 14 |
| n_g2_males i : | 5 |
| n_g2_females i : | 9 |
| disorder_g2 i : | Major Depressive Disorder |
| comorbidity_g2 i : | |
| premedication_g2 i : | None, antidepressants |
| medicated_g2 i : | 0 |
| days_wo_drugs_g2 i : | 180 |
| smoking_g2 i : | -1 |
| status i : | 1 |
| creation_time i : | 2022-08-18 12:33:44 |
| modification_time i : | 2024-05-30 11:42:33 |
| created_by i : | joupes |
| modified_by i : | lihsun |